EP0790832A1 - Topische präparate - Google Patents

Topische präparate

Info

Publication number
EP0790832A1
EP0790832A1 EP95912966A EP95912966A EP0790832A1 EP 0790832 A1 EP0790832 A1 EP 0790832A1 EP 95912966 A EP95912966 A EP 95912966A EP 95912966 A EP95912966 A EP 95912966A EP 0790832 A1 EP0790832 A1 EP 0790832A1
Authority
EP
European Patent Office
Prior art keywords
document
polymyxin
pharmaceutical formulation
bacitracin
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95912966A
Other languages
English (en)
French (fr)
Other versions
EP0790832A4 (de
Inventor
Shalom Isaac Benrimoj
Jane Heather Langford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Original Assignee
University of Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sydney filed Critical University of Sydney
Publication of EP0790832A1 publication Critical patent/EP0790832A1/de
Publication of EP0790832A4 publication Critical patent/EP0790832A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
EP95912966A 1994-11-11 1995-03-23 Topische präparate Withdrawn EP0790832A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM9396/94 1994-11-11
AUPM9396A AUPM939694A0 (en) 1994-11-11 1994-11-11 Topical preparation
PCT/AU1995/000159 WO1996014859A1 (en) 1994-11-11 1995-03-23 Topical preparation

Publications (2)

Publication Number Publication Date
EP0790832A1 true EP0790832A1 (de) 1997-08-27
EP0790832A4 EP0790832A4 (de) 1999-08-18

Family

ID=3783911

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95912966A Withdrawn EP0790832A4 (de) 1994-11-11 1995-03-23 Topische präparate

Country Status (4)

Country Link
EP (1) EP0790832A4 (de)
AU (1) AUPM939694A0 (de)
NZ (1) NZ282738A (de)
WO (1) WO1996014859A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2018864A1 (de) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmazeutische Zusammensetzung, Substrat mit einer pharmazeutischen Zusammensetzung und Verwendung einer pharmazeutischen Zusammensetzung
EP2018857A1 (de) * 2007-07-23 2009-01-28 Biomet Deutschland GmbH Medizinische Vorrichtung und Verwendung einer pharmazeutischen Zusammensetzung

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HOLDER I A: "Wet disc testing of mafenide hydrochloride, chlorhexidine gluconate, and triple antibiotic solution against bacteria isolated from burn wounds." JOURNAL OF BURN CARE AND REHABILITATION, (1990 JUL-AUG) 11 (4) 301-4. JOURNAL CODE: HLK. ISSN: 0273-8481., XP002106727 United States *
MYERS ET AL.: "Antibacterial activity of throat lozenges" CAN. J. PHARM. SCI., vol. 13, no. 3, 1978, pages 51-59, XP002106726 *
See also references of WO9614859A1 *

Also Published As

Publication number Publication date
NZ282738A (en) 1999-10-28
AUPM939694A0 (en) 1994-12-08
WO1996014859A1 (en) 1996-05-23
EP0790832A4 (de) 1999-08-18

Similar Documents

Publication Publication Date Title
US20040037897A1 (en) Treatment of drug resistant organisms
EP0241175A1 (de) Topische antimikrobielle pharmazeutische Zusammensetzung enthaltend eine Silberverbindung und ein Azol
Modak et al. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds
JPH09132532A (ja) 抗生物質の抗菌力増強方法
CA2402611A1 (en) Bactericidal preparation
EP2094358B1 (de) Imidazole zur behandlung von multi-arznei-resistenten bakteriellen infektionen
US9248159B2 (en) MRSA bactericidal topical gel
JP2020533417A (ja) 抗菌組成物
IE52125B1 (en) 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quino-line carboxylic acid and metal salts thereof useful in burn therapy
US4535078A (en) Antibacterial composition comprising silver sulfadiazine and sodium piperacillin
CN103233058A (zh) 一种测试抗菌药物对病原微生物敏感性的方法
Beunders Development of antibacterial resistance: the Dutch experience
EP2317998B1 (de) Kombination aus fulvinsäure und einem antibiotikum
Roy et al. Clinical and in vitro efficacy of amoxicillin against bacteria associated with feline skin wounds and abscesses
WO1985001208A1 (en) Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof and silver sulfadiazine
WO1996014859A1 (en) Topical preparation
Rosenkranz A synergistic effect between cerium nitrate and silver sulphadiazine
Davis et al. A comparative double-blind randomised study of single dose fosfomycin trometamol with trimethoprim in the treatment of urinary tract infections in general practice
AU2062495A (en) Topical preparation
Booth et al. In vitro interactions of neomycin sulfate, bacitracin, and polymyxin B sulfate
Chevretton et al. Mastoidectomy packs: Xeroform® or BIPP?
JP3054758B2 (ja) 外傷用組成物
US5985291A (en) Method of treating infections using mupirocin chlorhexidene
Cooper et al. The role of antimicrobial agents in wound care
WO2005107774A1 (en) Pharmaceutical wound healing composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970509

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990707

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020528